cover image - Saunders Nursing Drug Handbook 2028 - Elsevier E-Book on VitalSource, 1st Edition
ISBN: 9780443387296
Copyright: 2028
Page Count: 1504
Imprint: Saunders
List Price: $38.99

Saunders Nursing Drug Handbook 2028 - Elsevier E-Book on VitalSource, 1st Edition

by Robert Kizior, BS, RPh and Keith Hodgson, RN, BSN, CCRN

Elsevier eBook on VitalSource

cover image - Saunders Nursing Drug Handbook 2028 - Elsevier E-Book on VitalSource, 1st Edition
ISBN: 9780443387296
Copyright: 2028
Page Count: 1504
Imprint: Saunders
List Price: $38.99

$38.99

Or $0.00 with a valid access code
Not Yet Available
Coming Soon!
Expected availability date: 02-15-2027
Saunders Nursing Drug Handbook 2028 provides you with current, detailed information on more than 1,000 generic and 4,000 trade name drugs. This handy, user-friendly guide includes updated uses, dosage forms, warnings, side effects and adverse reactions, IV drug administration, nursing considerations, and much more. Organized alphabetically by generic drug name for quick reference, this book stands out from the others in guiding the nurse through the steps essential to quality patient care.
    • New drug monographs for approximately 20-30 newly approved drugs by the FDA provide readers with the most current drug information
    • Each monograph is read and updated as necessary with new interactions, precautions, alerts, patient teaching instructions, and other need-to-know information included throughout as needed
    • Current information helps nurses feel confident in the accuracy of the information and helps prevent medication dispensing errors
    • Additional drug monographs housed on a QR-coded website
    • More than 1,000 generic name drugs (encompassing over 4,000 trade name drugs) organized alphabetically with A to Z tabs provide users with quick and easy access
    • Lists all newly approved drugs in the front of the book
    • Detailed information for each drug distinguishes side effects and adverse reactions and lists the effect or reaction by frequency of occurrence to allow the nurse to easily identify which are most likely to occur
    • Promotes safe drug administration by including a special text treatment for "High-Alert" drugs and includes an appendix for drug names that sound alike and look alike to highlight drugs that pose the greatest risk for patient harm
    • Therapeutic and toxic blood level information is incorporated in the Interactions section and under Nursing Implications and provides users with patient implications for drug administration
    • Lifespan and disorder-related dosage variations focus on pediatric, geriatric, hepatic, and immune- or renal-compromised patients to inform users of special considerations for specific patient populations
    • Incorporates frequently used herb monographs which are featured in the A to Z portion of the book with additional herb information in the appendix to inform users of common herbs that they may encounter
    • Organizes nursing implications in a functional nursing process framework and includes headings for Baseline Assessment, Intervention/Evaluation, and Patient/Family Teaching presenting the information in a way that is relevant to nurses
    • Extensively expanded IV content features a heading for IV compatibilities, and expanded rates of infusion, reconstitutions, drip rates, test doses, flushing, and incompatibilities
    • Covers herbal interactions noted within drug entries and provides valuable drug safety information
    • The Classifications section features an overview of actions and uses for drug families to give users a snapshot of the important drug information for each drug class
    • Top 100 drugs help users identify the most frequently administered drugs
    • Fixed combinations included in dosages of each combined drug directly within the individual monographs help readers understand different drug dose options for specific diseases
    • Cross references 400 top U.S. brand name drugs directly in the main section of the book making drug info quick and easy to locate. Cross references include page numbers for easier accessibility
    • Free access to the Evolve site which features appendices
    • Comprehensive foldout IV Compatibility Chart provides compatibility information for 65 intravenous drugs.
  • How to Use This Book
    Contents List of newly approved drugs
    Evolve Page IV Compatibility Chart Insert Drugs by Disorder

    Section I. Drug Classifications
    Section II. A-Z Drugs
    Section III. Reference Section (NOTE: MOVE TO EVOLVE SITE)

    Appendix
    A. Calculation of Doses (NOTE: MOVING APPENDICES TO EVOLVE SITE)
    B. Controlled Drugs (United States)
    C. Chronic Wound Care
    D. Drugs of Abuse
    E. Equianalgesic Dosing
    F. FDA Pregnancy Categories
    G. Herbals: Common Natural Medicines
    H. Lifespan, Cultural Aspects, and Pharmacogenomics of Drug Therapy
    I. Normal Laboratory Values
    J. Cytochrome P450 (CYP) Enzymes
    K. Poison Antidote Chart
    L. Preventing Medication Errors and Improving Medication Safety
    M. Recommended Childhood and Adult Immunizations
    N. Parenteral Fluid Administration
    O. Spanish Phrases Often Used in Clinical Settings General Index Commonly Used Abbreviations Dangerous
  • Robert Kizior, BS, RPh, Pharmacist (retired), Department of Pharmacy, Alexian Brothers Medical Center, Elk Grove Village, Illinois; Former Adjunct Faculty Member at William Rainey Harper Community College, Palatine, Illinois, USA and Keith Hodgson, RN, BSN, CCRN
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • All content can be read as read aloud speech or dynamic braille
    • Conformance
      • The certifier's credential is https://bornaccessible.benetech.org/certified-publishers/
      • For detailed accessibility information, see Elsevier's website at https://www.elsevier.com/about/accessibility
      • For queries regarding accessibility information, contact [email protected]
      • The publication was certified on 07-04-2026
    • Navigation
      • Table of contents to all chapters of the text via links
      • Page list to go to pages from the print source version
    • Rich Content
      • No information is available
    • Hazards
      • No information is available
    • Product Content
      • No information is available
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Content is enhanced with ARIA roles to optimize organization and facilitate navigation
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • The body text is presented with a contrast ratio of at least 4.5:1 (or 3:1 for large/heading text)
      • Ultra-high contrast between text and background
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • Where interactive content is included in the product, controls are provided (e.g., for speed, pause and resume, reset) and labelled to make their use clear.
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.

$38.99

Or $0.00 with a valid access code
Not Yet Available
Coming Soon!
Expected availability date: 02-15-2027